News Release 9-Jan-2020 New insulin compound could improve therapy for diabetes patients Peer-Reviewed Publication The Florey Institute of Neuroscience and Mental Health ...

The discovery of a new insulin compound could improve the delivery of insulin for people with insulin-dependent diabetes, according to researchers. A non-fibrillating form of human insulin, called ...

In what can cause significant patient burden and medicine wastage, insulin pump infusion sets are required to be replaced every 24 hours to 72 hours to mitigate the occurrence of fibrils. In the USA ...

HPH-15 not only improved insulin sensitivity but also lowered blood glucose levels from 11.1 mmol/L to 8.2 mmol/L at a dose of 10 mg/kg and to 7.9 mmol/L at 100 mg/kg.

Global Insulin-Sensitizing Agents Market to Reach USD 22.1 Billion by 2025, Growing at 5% CAGR Through 2032 The global Insulin-Sensitizing Agents Market is poised for steady expansion, projected to ...

Written by Editorial Team | Published : May 23, 2014 11:41 AM IST ...

The insulin market, dominated by old drugs that have skyrocketed in price, is on the verge of a shakeup. The first “follow-on” insulin for diabetics, similar to a generic medication for ...

More for You Greenland lawmakers form a new government on the eve of Vance visit Non Sequitur by Wiley Miller Energy chief slashes red tape that led to 60% cost in inflation, burdened work in ...

A compound in brewer’s yeast that mimics the effects of insulin could help to prevent cataracts and eye damage in diabetics, suggests an animal study published online in Experimental Biology and ...

A compound formed during insulin production and once dismissed as irrelevant in diabetes may be a key to preventing the complications that make Type 1 diabetes such a serious disease, according to ...